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The ability of a rapid, latex agglutination test to diagnose rubella infection and to measure NT . The correlation coefficient between NT and latex agglutination titers was statistically significant. There was one serum positive by latex agglutination but negative by NT, and five sera were negative by latex agglutination but had titers of 4 to 8 in the NT. The relative sensitivity of detecting antibody was greater by latex agglutination than by HAI. An additional 49 sera containing residual nonspecific hemagglutinin inhibitors were evaluated by latex agglutination and NT. The untreated sera showed no false positive reactions, and 36 of 39 NT positive sera were positive in the latex agglutination test.
The hemagglutination-inhibition (HAI) test is currently the most widely accepted method for both serological diagnosis of rubella infection and determination of immune status. However, the HAI test is time-consuming, labor intensive, and difficult to standardize between laboratories (10). For example, the average values from annual proficiency testing between 1971 and 1979 indicated 21.1 to 37.2% of HAI results from U.S. laboratories fell outside the acceptable variation range (23) . An additional problem encountered in the HAI test is that 5 to 10% of treated test sera display residual nonspecific inhibitors which cause abnormal patterns of reactivity and make the results difficult to interpret (3, 19, 28) .
Several other antibody assays have recently been developed and tested including: radioimmunoassay (18) , passive hemagglutination (1), single radial hemolysis in gel (4, 5) , indirect immunofluorescence test (4, 6) , and enzymelinked immunosorbent assay (ELISA; 25, 26) . These tests are rapid, simple, and usually require no pretreatment of sera. Numerous reports (2, 4, 6-8, 19, 24, 28) (20) .
ELISA. The method for growing and purifying rubella virus was basically as outlined previously (17) . However, before sucrose gradient ultracentrifugation, the virus was concentrated by membrane filtration (Pellicon cassette; Millipore Corp., Bedford, Mass.). Those fractions from the gradient which showed peak hemagglutinating activity were pooled and used as antigens. A negative control antigen was prepared in an identical manner from mock-infected cells disrupted by one freeze-thaw cycle.
The optimum dilution of all reagents used in the ELISA was determined by checkerboard titrations. A volume of 0.1 ml per well was used for all incubations. The washing procedure between each step consisted of five successive washes with 0.2 ml of phosphatebuffered saline with 0.05% Tween 20 using an automatic washing apparatus (Miniwash; Dynatech Laboratories, Inc., Alexandria, Va.). Test sera were diluted in twofold steps starting at 1:50 in phosphate-buffered saline-Tween 20 containing 0.1% bovine serum albumin and 50 ,ug of dextran sulfate per ml (analytical grade; ICN, Cleveland, Ohio). Anti-human immunoglobulin G, conjugated with alkaline phosphatase (Sigma Chemical Co., St. Louis, Mo.) was diluted in the same buffer.
The ELISA followed previously established methodology (27) . The rubella antigen (and the negative control antigen adjusted to an equal protein concentration) was diluted in 0.06 M carbonate coating buffer (pH 9.6) (27) In reading the results, a specific activity was calculated for each serum dilution by subtracting the average optical density in duplicate wells coated with negative control antigen from the optical density of the wells coated with rubella antigen. A series of at least five antibody-negative sera were also included in each assay, and a dilution of serum was considered positive only if it yielded a specific activity which was 2.5 standard deviations greater than the mean specific activity of these negative sera.
In comparative studies, we found that antibody titers using this ELISA method were generally two-to fourfold higher than those obtained when testing dilutions of sera with two commercially available kits.
Latex agglutination test. The procedure followed was that recommended in the Rubascan latex agglutination kit. The test involves placing 0.025 ml of untreated serum on an imprinted circle on a Tefloncoated card. An applicator was used to spread the serum to cover the encircled area. One drop (approximately 0.015 ml) of rubella virus-coated latex beads was added to the serum. The card was placed in a humid chamber on a rotating shaker (100 rpm) at room temperature for 8 min, and agglutination was then read with the aid of a high-intensity incandescent lamp. The kit provided positive and negative control sera to be included on each card. To determine end-point titrations, twofold dilutions of sera were made with dilution buffer contained in the kit. The antibody titer was recorded as the reciprocal of that dilution which when mixed with a drop of latex beads produced agglutination. Therefore, a serum yielding agglutination only in the undiluted state was recorded as a titer of 1.
During this study, we encountered a small percentage of antibody-positive sera which yielded a weak agglutination when tested undiluted, but showed strong agglutination upon dilution. Consequently, all sera were initially tested both undiluted and diluted 1:4.
Complement fixation test. The complement fixation test was performed as previously described (11) . RESULTS Detection of seroconversion. Paired sera from 21 persons with natural infection and from 53 who had been immunized with various vaccines were tested in ELISA, latex agglutination, and HAI tests. Postinfection or postvaccination sera were collected 30 to 60 days after infection or immunization. The latex agglutination test accurately detected seroconversions in all pairs of sera ( Table 1) .
Determination of immune status. Sera from 276 individuals submitted to our laboratory for determination of immune status were tested by HAI, ELISA, and latex agglutination. Figure 1 shows the titers obtained in the HAI and latex agglutination tests. The overall agreement between the tests was 97.5% (269 of 276 sera); the Spearman rank coefficient of antibody containing sera was r = 0.662, indicating that the relationship between titers was statistically significant (P < 0.001). Figure 2 presents a comparison of titers from the ELISA and the latex agglutination test. The overall agreement was 98.6% (272 of 276 sera); the correlation coefficient was r = 0.639, and it was significant (P < 0.001). Table 2 gives results on 12 sera which showed a disparity when tested for antibody in the experiments depicted in Fig. 1 and 2 . Although no sera were positive by HAI and negative in the latex agglutination test, eight were negative by HAI and positive in the latex agglutination test (Fig. 1) . No sera were negative by ELISA and positive in the latex agglutination test, but four were ELISA positive and latex agglutination (and HAI) negative (Fig. 2) Fig. 3 . Overall agreement was 97.5% (191 of 196) ; the correlation coefficient was r = 0.593, and the relationship between titers of antibody containing sera was statistically significant (P < 0.001). Table 2 shows that seven of the eight sera negative by HAI but positive in the latex agglutination test were positive by NT with titers from 8 to 32. The one false positive result was with a serum that agglutinated only at an undiluted concentration, and was positive in the ELISA at 1:100. Three of the four sera positive in the ELISA but negative by latex agglutination test (Table 2) had NT titers from 4 to 8. We detected two sera with NT titers of 4 and 8 which were negative in all other tests.
Relative test sensitivities. Of the 196 sera tested by NT, 111 were positive (NT titer, -4) and were used to determine the relative sensitivities of the HAI, ELISA, and latex agglutination tests. This group of 111 sera included 28 with low levels of antibody, i.e., .8 by the standard short-incubation HAI method. The sensitivity of the HAI was 91% (101 of 111), and that of the latex agglutination was 95.5% (106 of 111) with one false positive result. The sensitivity of the ELISA was 98.2% (109 of 111) with two false positive results, both titering 100.
Measurement of complement-fixing antibodies. To ascertain if the latex agglutination test was measuring complement-fixing antibodies, we used a previously assayed series of sera collected at 2-to 3-year intervals for 7 years from 12 individuals immunized with RA27/3 vaccine. The initial postimmunization complement fixation antibody titer disappeared, but the antibody measured by latex agglutination remained positive through 7 years and correlated with the titer determined by HAI and ELISA (data not shown). There was one positive serum in the latex agglutination test and two in the ELISA (one of which was latex agglutination positive) which were negative by NT. The problem of false positive reactions has been encountered in previous studies using ELISA (7, 19, 21) . Although the methodology was modified in attempts to reduce these problems (2, 7, 8, 14, 24, 29) , it was not always possible to determine whether the results were false positives or whether the ELISA was more sensitive than the HAI test used as reference (7, 21) . Best et al. (1) have shown the ELISA to be more sensitive than HAI; similarly 10 of 12 of the ELISA positive-HAI negative sera reported above were NT positive.
It is possible that the ELISA and latex agglutination false-positive results represent detection of rubella-specific nonneutralizing antibody, since it has been shown that a small percentage of persons who acquire rubella infections naturally, and some vaccinated with HPV77DE5, develop HAI but not NT antibody (9, 15, 22 
